TO THE EDITOR: The proposal by our well-respected colleagues (2) to introduce a new metric-incorporating the altitude elevation and the total exposure duration, termed "kilometer hours"-for better describing the "hypoxic dose" is decidedly a step forward. By only quantifying the "external" stress, this metric presents several limitations: It suggests a linear relationship between altitude elevation and saturation decrease [but the Fick curve is curvilinear (3)] or that it applies to all athletes irrespectively of their training background [but elite endurance athletes suffer the largest decrease in V O 2max (1)], altitude experience [but elite athletes who have had previous hypoxic exposure better adapt to hypoxic condition (4)], or type of hypoxia [but hypobaric vs. normobaric hypoxia induces larger desaturation (5)].
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COMMENTARY ON VIEWPOINT: TIME FOR A NEW METRIC HYPOXIC DOSE?
TO THE EDITOR: It is a very good idea of Garvican-Lewis, Sharpe, and Gore (2) to initiate this discussion with a new metric hypoxic dose by combining living altitude in kilometers with hours spent at altitude ("kilometer hours"; km·h) in the field of altitude training science. However, is the altitude component of the dose really linear? Would exposure at lower altitudes overestimate the hypoxic dose because some sort of "altitudethreshold" exists? Physiological mechanisms behind a possible "altitude-threshold" could be associated with the s-shape of the oxyhemoglobin saturation curve: at altitudes above ϳ2,000 m the desaturation of athletes would occur on the steeper part of the curve resulting in more substantial increases in sEpo (ϳ90% at 2,400 m compared with ϳ30% at 1,800 m after 24 h) (1) . As the authors indicated, most recommendations for natural living altitudes are between 2,000 and 2,500 m (2, 5). Our Swiss experiences are that only ϳ1/6 of the endurance athletes living at 1,800 m (4) and 2/3 living at 2,200 m (3) have a substantially increased hemoglobin mass after a 3-week altitude training camp. Could the proposed method be "optimized," if "kilometer" is weighted in a way, that there is a larger dose-difference for altitudes below and above an "altitude-threshold"? For example, start counting kilometers above 1,300 m, with double hours at 1,800 m needed to reach the same "dose" as compared with 2,300 m. Additionally, for elite sport settings, one should also keep in mind that the hemoglobin-mass-response to a given "dose" has been shown to be largely idiosyncratic, thereby requiring individualized recommendations (3, 4) .
with all athletes showing a positive response. Siebenmann et al. (4) reported no change in average Hb mass after 1,328 km·h (4 wk, 16 h/day, 3,000 m). This greater dose was beneficial for some athletes, but trivial or detrimental for others, leading to no change on average. With an average 6% increase in red cell mass volume, Chapman et al. (1) did not show any dose response effect after 4 wk "living high, training high and low" between 1,780, 2,085, 2,454, and 2,800 m. Their study suggests that increasing the dose by increasing the altitude above optimum may not provide any benefit (1). After more extreme hypoxic dose, a 72-day self-supported Mt. Everest expedition (Ͼ9,000 km·h), Cheung et al. (2) reported a wide scale of positive, negative, and no change responses in Hb mass . Thus the suggested model and the present literature, analogously with our own unpublished data using the km·h approach, rather highlight the need for careful evaluation of all factors influencing athletes' adaptation than solves the problem of how to determine hypoxic dose in elite sports.
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COMMENTARY ON VIEWPOINT: TIME FOR A NEW METRIC FOR HYPOXIC DOSE?
TO THE EDITOR: Although exposure to some effective dose of hypobaric hypoxia provides a clear stimulus to increase hemoglobin (Hb) mass (3), numerous physiological responses to normobaric hypoxia have well documented differences to hypobaric hypoxia (4) . Because of these discrepancies, we believe the conditions should not be treated as equal, and other meta-analyses (e.g., Ref. 1) have differentiated between "natural" and "artificial" hypoxic exposures. Additionally, given that all but one of the included studies consisted of highly trained subjects, the authors may wish to exclude the Siebenmann et al. study (5) , which described subjects as "sedentary to moderately trained individuals who were not involved in highlevel sport." Finally, the model would benefit from a clear establishment of a minimum threshold, both from an altitude and a duration perspective, as the authors note both short duration high/extreme altitude exposure and chronic residence at mild altitude are each ineffective at increasing Hb mass.
We would be excited to see an expanded model that accounts for the above concerns, thus addressing the sensitivity in what is already a thin air of certainty in regards to hypoxic training.
TO THE EDITOR: Guidelines for simulated altitude exposure suggest athletes should spend around 14 h per day at 3,000 m for 3 weeks (300 h of exposure) to observe a mean increase in hemoglobin mass of 3-5% (3). Similarly, hypoxic exposure for 3-4 weeks at Ͼ2,200 m altitude will elicit a 3-5% increase in hemoglobin mass (2) , with 4 weeks exposure believed to accelerate erythropoiesis (4) . Hypoxia in both these occasions is influenced by altitude and the duration of hypoxia. The new metric of hypoxic dosing (1) addresses this problem, ensuring standardization of the hypoxic dose at various altitudes and hence will allow for comparing physiologic and nonphysiologic effects on body systems. The hypoxic dose as per the new metric for the studies mentioned above will be 882-1,478 km·h (2, 3). There have been questions regarding the minimum altitude and the extent of duration that results in "hypoxic dose" for physiologic changes to occur. The new metric is a good starting point that combines altitude and duration to measure outcomes across studies. The hypoxic dose per the new metric is predominantly in the range of 600-1,500 km·h that results in 3-6% change in hemoglobin mass across multiple studies (1) . As the relationship between altitude and hypoxia is not exactly linear and various factors could influence physiologic adaptation or training performance, knowing the baseline ("hypoxic dose") will make interpretation more well defined. The new metric may help to further characterize the minimum "dose" required for optimal performance, percent change in hemoglobin mass and other measures of physiologic adaptation.
